Report Detail

According to our (Global Info Research) latest study, the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Ultrasound-guided non-invasive diagnosis of liver fibrosis can simultaneously obtain two indicators, the degree of liver fibrosis and the quantitative fatty liver, for the quantitative detection of liver fibrosis and fatty liver. This technology is suitable for all people of medium body size, and can roughly determine the degree of liver fibrosis without liver biopsy.
The devices currently available in the medical community to assess liver fibrosis and liver stiffness include Fibroscan and Acoustic Radiation Force Impulse imaging (ARFI, Acoustic Radiation Force Impulse imaging), two commonly used ultrasound instruments, as well as magnetic resonance imaging with special software. Imaging instruments, etc. Among them, liver fiber scanner should be the most commonly used method in clinical examination at present.
This report is a detailed and comprehensive analysis for global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Technology and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market size and forecasts, by Technology and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (K US$/Unit), 2020-2031
Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (K US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Echosens, Hisky Med, Eieling Technology, Mindray, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market is split by Technology and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Technology, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Technology
Transient Elastography
Acoustic radiation force impulse (ARFI) Imaging
Market segment by Application
Hospitals
Imaging Centers
Major players covered
Echosens
Hisky Med
Eieling Technology
Mindray
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis, with price, sales quantity, revenue, and global market share of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis from 2020 to 2025.
Chapter 3, the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Technology and by Application, with sales market share and growth rate by Technology, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market forecast, by regions, by Technology, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis.
Chapter 14 and 15, to describe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Technology
    • 1.3.1 Overview: Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Technology: 2020 Versus 2024 Versus 2031
    • 1.3.2 Transient Elastography
    • 1.3.3 Acoustic radiation force impulse (ARFI) Imaging
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals
    • 1.4.3 Imaging Centers
  • 1.5 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size & Forecast
    • 1.5.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity (2020-2031)
    • 1.5.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Echosens
    • 2.1.1 Echosens Details
    • 2.1.2 Echosens Major Business
    • 2.1.3 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product and Services
    • 2.1.4 Echosens Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Echosens Recent Developments/Updates
  • 2.2 Hisky Med
    • 2.2.1 Hisky Med Details
    • 2.2.2 Hisky Med Major Business
    • 2.2.3 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product and Services
    • 2.2.4 Hisky Med Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Hisky Med Recent Developments/Updates
  • 2.3 Eieling Technology
    • 2.3.1 Eieling Technology Details
    • 2.3.2 Eieling Technology Major Business
    • 2.3.3 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product and Services
    • 2.3.4 Eieling Technology Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Eieling Technology Recent Developments/Updates
  • 2.4 Mindray
    • 2.4.1 Mindray Details
    • 2.4.2 Mindray Major Business
    • 2.4.3 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Product and Services
    • 2.4.4 Mindray Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Mindray Recent Developments/Updates

3 Competitive Environment: Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Manufacturer

  • 3.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Revenue by Manufacturer (2020-2025)
  • 3.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Manufacturer Market Share in 2024
  • 3.5 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market: Overall Company Footprint Analysis
    • 3.5.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market: Region Footprint
    • 3.5.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market: Company Product Type Footprint
    • 3.5.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Region
    • 4.1.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Region (2020-2031)
    • 4.1.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price by Region (2020-2031)
  • 4.2 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value (2020-2031)
  • 4.3 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value (2020-2031)
  • 4.5 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value (2020-2031)

5 Market Segment by Technology

  • 5.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Technology (2020-2031)
  • 5.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Technology (2020-2031)
  • 5.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price by Technology (2020-2031)

6 Market Segment by Application

  • 6.1 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Application (2020-2031)
  • 6.2 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Application (2020-2031)
  • 6.3 Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Technology (2020-2031)
  • 7.2 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Application (2020-2031)
  • 7.3 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country
    • 7.3.1 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Technology (2020-2031)
  • 8.2 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Application (2020-2031)
  • 8.3 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country
    • 8.3.1 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Technology (2020-2031)
  • 9.2 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Region
    • 9.3.1 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Technology (2020-2031)
  • 10.2 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Application (2020-2031)
  • 10.3 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country
    • 10.3.1 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Technology (2020-2031)
  • 11.2 Middle East & Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Size by Country
    • 11.3.1 Middle East & Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Drivers
  • 12.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market Restraints
  • 12.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis
  • 13.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Typical Distributors
  • 14.3 Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis. Industry analysis & Market Report on Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis is a syndicated market report, published as Global Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Ultrasound-guided Non-invasive Diagnostic of Liver Fibrosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report